Clinical Trial Update: Ten-Year Outcomes of Operable Solitary Hepatocellular Carcinoma Patients: Impact of Tumor Size Over 6.5 cm and Microvascular Invasion

View source ↗

Summary

This clinical trial examines ten-year outcomes for operable solitary hepatocellular carcinoma, evaluating the impact of tumor size over 6.5 cm and microvascular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Hepatocellular Carcinoma (HCC), Solitary Mass | Status: RECRUITING